RNA-binding protein is involved in aggregation of light neurofilament protein and is implicated in the pathogenesis of motor neuron degeneration

Human Molecular Genetics

Volumn 14, Issue 23, 2005, Pages 3643-3659

  Lin, Hong ^a   Zhai, Jinbin ^a   Schlaepfer, William W ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; LIGHT NEUROFILAMENT PROTEIN; MESSENGER RNA; MUTANT PROTEIN; NEUROFILAMENT PROTEIN; PROTEIN P190RHOGEF; PROTEIN SUBUNIT; RNA BINDING PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; MOTOR NEURON DISEASE; MOUSE; NERVE CELL DEGENERATION; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; TRANSGENE; UBIQUITINATION;

ANIMALS; CARRIER PROTEINS; DNA-BINDING PROTEINS; GTPASE-ACTIVATING PROTEINS; MICE; MICE, TRANSGENIC; MOTOR NEURON DISEASE; MOTOR NEURONS; NERVE DEGENERATION; NEUROFILAMENT PROTEINS; REPRESSOR PROTEINS; RNA INTERFERENCE; RNA STABILITY; RNA, MESSENGER; RNA-BINDING PROTEINS; SOLUBILITY;

ANIMALIA; MUS MUSCULUS;

EID: 27744597388     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddi392     Document Type: Article

References (94)

1. Glatzel, M., Stoeck, K., Seeger, H., Luhrs, T. and Aguzzi, A. (2005) Human prion diseases: Molecular and clinical aspects. Arch. Neurol., 62, 545-552.
2. Goedert, M. and Jakes, R. (2005) Mutations causing neurodegenerative tauopathies. Biochim. Biophys. Acta, 1739, 240-250.
3. Kuret, J., Chirita, C.N., Congdon, E.E., Kannanayakal, T., Li, G., Necula, M., Yin, H. and Zhong, Q. (2005) Pathways of tau fibrillization. Biochim. Biophys. Acta, 1739, 167-178.
4. Muchowski, P.J. and Wacker, J.L. (2005) Modulation of neurodegeneration by molecular chaperones. Nat. Rev. Neurosci., 6, 11-22.
5. von Bergen, M., Barghorn, S., Biernat, J., Mandelkow, E.M. and Mandelkow, E. (2005) Tau aggregation is driven by a transition from random coil to beta sheet structure. Biochim. Biophys. Acta, 1739, 158-166.
6. Ross, C.A. and Poirier, M.A. (2004) Protein aggregation and neurodegenerative disease. Nat. Med., 10 (suppl), S10-S17.
7. Stoppini, M., Andreola, A., Foresti, G. and Bellotti, V. (2004) Neurodegenerative diseases caused by protein aggregation: A phenomenon at the borderline between molecular evolution and ageing. Pharmacol. Res., 50, 419-431.
8. Glabe, C.C. (2005) Amyloid accumulation and pathogensis of Alzheimer's disease: Significance of monomeric, oligomeric and fibrillar Abeta. Subcell. Biochem., 38, 167-177.
9. Arrasate, M., Mitra, S., Schweitzer, E.S., Segal, M.R. and Finkbeiner, S. (2004) Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature, 431, 805-810.
10. Caughey, B. and Lansbury, P.T. (2003) Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders. Anna. Rev. Neurosci., 26, 267-298.
11. Sanchez, I, Mahlke, C. and Yuan, J. (2003) Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders. Nature, 421, 373-379.
12. Walsh, D.M., Klyubin, I, Fadeeva, J.V., Cullen, W.K., Anwyl, R., Wolfe, M.S., Rowan, M.J. and Selkoe, D.J. (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature, 416, 535-539.
13. Strong, M.J. and Gordon, P.H. (2005) Primary lateral sclerosis, hereditary spastic paraplegia and amyotrophic lateral sclerosis: discrete entities or spectrum? Amyotroph. Lateral Scler. Other Motor Neuron Disord., 6, 8-16.
14. Bruijn, L.I., Miller, T.M. and Cleveland, D.W. (2004) Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci., 27, 723-749.
15. Wood, J.D., Beaujeux, T.P. and Shaw, P.J. (2003) Protein aggregation in motor neurone disorders. Neuropathol. Appl. Neurobiol., 29, 529-545.
16. Robertson, J., Kriz, J., Nguyen, M.D. and Julien, J.P. (2002) Pathways to motor neuron degeneration in transgenic mouse models. Biochimie, 84, 1151-1160.
17. Antonyuk, S., Elam, J.S., Hough, M.A., Strange, R.W., Doucette, P.A., Rodriguez, JA., Hayward, L.J., Valentine, J.S., Hart, P.J. and Hasnain, S. S. (2005) Structural consequences of the familial amyotrophic lateral sclerosis SOD1 mutant His46Arg. Protein Sci., 14, 1201-1213.
18. Furukawa, Y. and O'Halloran, T.V. (2005) Amyotrophic lateral sclerosis mutations have the greatest destabilizing effect on the apo- andreduced form of SOD1, leading to unfolding and oxidative aggregation. J. Biol. Chem., 280, 17266-17274.
19. Lindberg, M.J., Bystrom, R., Boknas, N., Andersen, P.M. and Oliveberg, M. (2005) Systematically perturbed folding patterns of amyotrophic lateral sclerosis (ALS)-associated SOD1 mutants. Proc. Natl Acad. Sci. USA, 102, 9754-9759.
20. Arnesano, F., Banci, L., Bertim, I, Martinelli, M., Furukawa, Y. and O'Halloran, T.V. (2004) The unusually stable quaternary structure of human Cu, Zn-superoxide dismutase 1 is controlled by both metal occupancy and disulfide status. J. Biol. Chem., 279, 47998-48003.
21. Hough, M.A., Grossmann, J.G., Antonyuk, S.V., Strange, R.W., Doucette, P.A., Rodriguez, JA., Whitson, L.J., Hart, P.J., Hayward, L.J., Valentine, J.S. et al. (2004) Dimer destabilization in superoxide dismutase may result in disease-causing properties: Structures of motor neuron disease mutants. Proc. Natl Acad. Sci. USA, 101, 5976-5981.
22. Khare, S.D., Caplow, M. and Dokholyan, N.V. (2004) The rate and equilibrium constants for a multistep reaction sequence for the aggregation of superoxide dismutase in amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA, 101, 15094-15099.
23. Lindberg, M.J., Normark, J., Holmgren, A. and Oliveberg, M. (2004) Folding of human superoxide dismutase: Disulfide reduction prevents dimerization and produces marginally stable monomers. Proc. Natl Acad. Sci. USA, 101, 15893-15898.
24. Rakhit, R., Crow, J.P., Lepock, J.R., Kondejewski, L.H., Cashman, N.R. and Chakrabartty, A. (2004) Monomeric Cu, Zn-superoxide dismutase is a common misfolding intermediate in the oxidation models of sporadic and familial amyotrophic lateral sclerosis. J Biol. Chem., 279, 15499-15504.
25. Valentine, J.S. and Hart, P.J. (2003) Misfolded CuZnSOD and amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA, 100, 3617-3622.
26. Wang, J., Xu, G., Li, H., Gonzales, V., Fromholt, D., Karch, C., Copeland, N.G., Jenkins, N.A. and Borchelt, D.R. (2005) Somatodendritic accumulation of misfolded SODl-L126Z in motor neurons mediates degeneration: αB-crystallin modulates aggregation. Hum. Mol. Genet., 14, 2335-2347.
27. Watanabe, Y., Yasui, K., Nakano, T., Doi, K., Fukada, Y., Kitayama, M., Ishimoto, M., Kurihara, S., Kawashima, M., Fukuda, H. et al. (2005) Mouse motor neuron disease caused by truncated SOD1 with or without C-terminal modification. Brain Res. Mol. Brain Res., 135, 12-20.
28. Jonsson, P.A., Ernhill, K., Andersen, P.M., Bergernalm, D., Brannstrom, T., Gredal, O., Nilsson, P. and Marklund, S.L. (2004) Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis. Brain, 127, 73-88.
29. Bennett, E.J., Bence, N.F., Jayakumar, R. and Kopito, R.R. (2005) Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation. Mol. Cell, 17, 351-365.
30. Corbo, M. and Hays, A.P. (1992) Peripherin and neurofilament protein coexist in spinal spheroids of motor neuron disease. J. Neuropathol. Exp. Neurol., 51, 531-537.
31. Murayama, S., Bouldin, T.W. and Suzuki, K. (1992) Inummocytochemical and ultrastructural studies of upper motor neurons in amyotrophic lateral sclerosis. Acta Neuropathol. (Berl.), 83, 518-524.
32. Leigh, P.N., Dodson, A., Swash, M., Brion, J.P. and Anderton, B.H. (1989) Cytoskeletal abnormalities in motor neuron disease. An immunocytochernical study. Brain, 112, 521-535.
33. Munoz, D.G., Greene, C., Perl, D.P. and Selkoe, D.J. (1988) Accumulation of phosphorylated neurofilaments in anterior horn motoneurons of amyotrophic lateral sclerosis patients. J Neuropathol. Exp. Neurol., 47, 9-18.
34. Morrison, B.M., Shu, I.W., Wilcox, A.L., Gordon, J.W. and Morrison, J.H. (2000) Early and selective pathology of light chain neurofilament in the spinal cord and sciatic nerve of G86R mutant superoxide dismutase transgenic mice. Exp. Neurol., 165, 207-220.
35. Irobi, J., De Jonghe, P. and Timmerman, V. (2004) Molecular genetics of distal hereditary motor neuropathies. Hum. Mol. Genet., 13 (Spec no. 2), R195-R202.
36. Young, P. and Suter, U. (2003) The causes of Charcot-Marie-Tooth disease. Cell. Mol. Life Sci., 60, 2547-2560.
37. Perez-Olle, R., Jones, S.T. and Liem, R.K. (2004) Phenotypic analysis of neurofilament light gene mutations linked to Charcot-Marie-Tooth disease in cell culture models. Hum. Mol. Genet., 13, 2207-2220.
38. Brownlees, J., Ackerley, S., Grierson, A.J., Jacobsen, N.J., Shea, K., Anderton, B.H., Leigh, P.N., Shaw, C.E. and Miller, C.C. (2002) Charcot-Marie-Tooth disease neurofilament mutations disrupt neurofilament assembly and axonal transport. Hum. Mol. Genet., 11, 2837-2844.
39. Perez-Olle, R., Leung, C.L. and Liem, RX. (2002) Effects of Charcot-Marie-Tooth-linked mutations of the neurofilament light subunit on intermediate filament formation. J. Cell Sci., 115, 4937-4946.
40. Evgrafov, O.V., Mersiyanova, L, Irobi, J., Van Den Bosch, L., Dierick, I, Leung, C.L., Schagina, O., Verpoorten, N., Van Impe, K., Fedotov, V. et al. (2004) Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nat. Genet., 36, 602-606.
41. Canete-Soler, R., Schwartz, M.L., Hua, Y. and Schlaepfer, W.W. (1998) Characterization of ribonucleoprotein complexes and their binding sites on the neurofilament light subunit mRNA. J. Biol. Chem., 273, 12655-12661.
42. Canete-Soler, R., Schwartz, M.L., Hua, Y. and Schlaepfer, W.W. (1998) Stability determinants are localized to the 3′-untranslated region and 3′-coding region of the neurofilament light subunit mRNA using a tetracycline-inducible promoter. J Biol. Chem., 273, 12650-12654.
43. Canete-Soler, R., Silberg, D.G., Gershon, M.D. and Schlaepfer, W.W. (1999) Mutation in neurofilament transgene implicates RNA processing in the pathogenesis of neurodegenerative disease. J Neurosci., 19, 1273-1283.
44. Nie, Z., Wu, J., Zhai, J., Lin, H., Ge, W., Schlaepfer, W.W. and Canete-Soler, R. (2002) Untranslated element in neurofilament mRNA has neuropathic effect on motor neurons of transgenic mice. J. Neurosci., 22, 7662-7670.
45. Lin, H., Zhai, J., Nie, Z., Wu, J., Memkoth, J.L., Schlaepfer, W.W. and Canete-Soler, R. (2003) Neurofilament RNA causes neurodegeneration with accumulation of ubiquitinated aggregates in cultured motor neurons. J Neuropathol. Exp. Neurol., 62, 936-950.
46. Lin, H., Zhai, J., Canete-Soler, R. and Schlaepfer, W.W. (2004) 3′ untranslated region in a light neurofilament (NF-L) mRNA triggers aggregation of NF-L and mutant superoxide di smutase 1 proteins in neuronal cells. J Neurosci., 24, 2716-2726.
47. Canete-Soler, R., Wu, J., Zhai, J., Shamim, M. and Schlaepfer, W.W. (2001) pl90RhoGEF Binds to a destabilizing element in the 3′ untranslated region of light neurofilament subunit mRNA and alters the stability of the transcript. J Biol. Chem., 276, 32046-32050.
48. Bruce, J., Schwartz, M.L., Shneidman, P.S. and Schlaepfer, W.W. (1993) Methylation and expression of neurofilament genes in tissues and in cell lines of the mouse. Brain Res. Mol. Brain Res., 17, 269-278.
49. Nguyen, M.D., Shu, T., Sanada, K., Lariviere, R.C., Tseng, H.C., Park, S.K., Julien, J.P. and Tsai, L.H. (2004) A NUDEL-dependent mechanism of neurofilament assembly regulates the integrity of CNS neurons. Nat. Cell Biol., 6, 595-608.
50. Sasaki, S., Warita, H., Murakami, T., Shibata, N., Komori, T., Abe, K., Kobayashi, M. and Iwata, M. (2005) Ultrastructural study of aggregates in the spinal cord of transgenic mice with a G93A mutant SOD1 gene. Acta Neuropathol. (Berl.), 109, 247-255.
51. Menzies, F.M., Grierson, A.J., Cookson, M.R., Heath, P.R., Tonikins, J., Figlewicz, D.A., Ince, P.G. and Shaw, P.J. (2002) Selective loss of neurofilament expression in Cu/Zn superoxide dismutase (SOD1) linked amyotrophic lateral sclerosis. J. Neurochem., 82, 1118-1128.
52. Wong, N.K., He, B.P. and Strong, M.J. (2000) Characterization of neuronal intermediate filament protein expression in cervical spinal motor neurons in sporadic amyotrophic lateral sclerosis (ALS). J Neuropathol. Exp. Neurol., 59, 972-982.
53. Bergeron, C., Beric-Maskarel, K., Muntasser, S., Weyer, L., Somerville, M.J. and Percy, M.E. (1994) Neurofilament light and polyadenylated mRNA levels are decreased in amyotrophic lateral sclerosis motor neurons. J. Neurnpathol. Exp. Neurol., 53, 221-230.
54. Sjogren, M. and Englund, E. (2004) Negative neurofilament light and tau immunostaining in frontotemporal dementia. Dement. Geriatr. Cogn. Disord., 17, 346-349.
55. Kuchel, G.A., Poon, T., Irshad, K., Richard, C., Julien, J.P. and Cowen, T. (1997) Decreased neurofilament gene expression is an index of selective axonal hypotrophy in ageing. Neuroreport, 8, 799-805.
56. Nakamura, Y., Hasimoto, R., Kashiwagi, Y., Miyamae, Y., Shinosaki, K., Nishikawa, T., Hattori, H., Kudo, T. and Takeda, M. (1997) Abnormal distribution of neurofilament L in neurons with Alzheimer's disease. Neurosci. Lett., 225, 201-204.
57. Kittur, S., Hoh, J., Endo, H., Tourtellotte, W., Weeks, B.S., Markesbery, W. and Adler, W. (1994) Cytoskeletal neurofilament gene expression in brain tissue from Alzheimer's disease patients. I. Decrease in NF-L and NF-M message. J Geriatr. Psychiatry Neurol., 7, 153-158.
58. McLachlan, DR., Lukiw, W.J., Wong, L., Bergeron, C. and Bech-Hansen, N.T. (1988) Selective messenger RNA reduction in Alzheimer's disease. Brain Res., 427, 255-261.
59. Stieber, A., Gonatas, J.O. and Gonatas, N.K. (2000) Aggregates of mutant protein appear progressively in dendrites, in periaxonal processes of oligodendrocytes, and in neuronal and astrocytic perikarya of mice expressing the SOD1 (G93A) mutation of familial amyotrophic lateral sclerosis. J Neurol. Sci., 177, 114-123.
60. Giasson, B.I., Forman, M.S., Higuehi, M., Golbe, L.I., Graves, C.L., Kotzbauer, P.T., Trojanowski, J.Q. and Lee, V.M. (2003) Initiation and synergistic fibrillization oftau and alpha-synuclein. Science, 300,636-640.
61. Williamson, T.L., Bruijn, L.I., Zhu, Q., Anderson, K.L., Anderson, S.D., Julien, J.P. and Cleveland, D.W. (1998) Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant. Proc. Natl Acad. Sci. USA, 95, 9631-9636.
62. Lariviere, R.C. and Julien, J.P. (2004) Functions of intermediate filaments in neuronal development and disease. J Neurobiol., 58, 131-148.
63. Cote, F., Collard, J.F. and Julien, J.P. (1993) Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: A mouse model of amyotrophic lateral sclerosis. Cell, 73, 35-46.
64. Xu, Z., Cork, L.C., Griffin, J.W. and Cleveland, D.W. (1993) Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell, 73, 23-33.
65. Gama Sosa, M.A., Friedrich, V.L., Jr, DeGasperi, R., Kelley, K., Wen, P.H., Senturk, E., Lazzarini, R.A. and Elder, G.A. (2003) Human midsized neurofilament subunit induces motor neuron disease in transgenic mice. Exp. Neurol., 184, 408-419.
66. Eyer, J. and Peterson, A. (1994) Neurofilament-deficient axons and perikaryal aggregates in viable transgenic mice expressing a neurofilament-beta-galactosidase fusion protein. Neuron, 12, 389-405.
67. Eyer, J., Cleveland, D.W., Wong, P.C. and Peterson, A.C. (1998) Pathogenesis of two axonopathies does not require axonal neurofilaments. Nature, 391, 584-587.
68. Lee, M.K., Marszalek, J.R. and Cleveland, D.W. (1994) A mutant neurofilament subunit causes massive, selective motor neuron death: implications for the pathogenesis ofhuman motor neuron disease. Neuron, 13, 975-988.
69. Meier, J., Couillard-Despres, S., Jacomy, H., Gravel, C. and Julien, J.P. (1999) Extra neurofilament NF-L subunits rescue motor neuron disease caused by overexpression of the human NF-H gene in mice. J Neuropathol. Exp. Neurol., 58, 1099-10110.
70. Perez-Olle, R., Lopez-Toledano, M.A., Goryunov, D., Cabrera-Poch, N., Stefanis, L., Brown, K. and Liem, R.K. (2005) Mutations in the neurofilament light gene linked to Charcot-Marie-Tooth disease cause defects in transport. J Neurochem., 93, 861-874.
71. Roy, S., Zhang, B., Lee, V.M. and Trojanowski, J.Q. (2005) Axonal transport defects: A common theme in neurodegenerative diseases. Acta Neuropathol. (Berl.), 109, 5-13.
72. Fischer, L.R., Culver, D.G., Tennant, P., Davis, A.A., Wang, M., Castellano-Sanchez, A., Khan, J., Polak, M.A. and Glass, J.D. (2004) Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Exp. Neurol., 185, 232-240.
73. Schaefer, A.M., Sanes, J.R. and Lichtman, J.W. (2005) A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis. J Comp. Neurol., 490, 209-219.
74. Gros-Louis, F., Lariviere, R., Gowing, G., Laurent, S., Camu, W., Bouchard, J.P., Meminger, V., Rouleau, G.A. and Julien, J.P. (2004) A frameshift deletion in peripherin gene associated with amyotrophic lateral sclerosis. J Biol. Chem., 279, 45951-45956.
75. Leung, C.L., He, C.Z., Kauftnann, P., Chin, S.S., Naini, A., Liem, R.K., Mitsumoto, H. and Hays, A.P. (2004) A pathogenic peripherin gene mutation in a patient with amyotrophic lateral sclerosis. Brain Pathol., 14, 290-296.
76. Al-Chalabi, A., Andersen, P.M., Nilsson, P., Chioza, B., Andersson, J.L., Russ, C., Shaw, C.E., Powell, J.F. and Leigh, P.N. (1999) Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum. Mol. Genet., 8, 157-164.
77. Tomkins, J., Usher, P., Slade, J.Y., Ince, P.G., Curtis, A., Bushby, K. and Shaw, P.J. (1998) Novel insertion in the KSP region ofthe neurofilament heavy gene in amyotrophic lateral sclerosis (ALS). Neuroreport, 9, 3967-3970.
78. Figlewicz, D.A., Krizus, A., Martinoli, M.G., Meminger, V., Dib, M., Rouleau, G.A. and Julien, J.P. (1994) Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum. Mol. Genet., 3, 1757-1761.
79. Ching, G.Y. and Liem, R.K. (1993) Assembly of type IV neuronal intermediate filaments in nonneuronal cells in the absence of preexisting cytoplasmic intermediate filaments. J Cell Biol., 122, 1323-1335.
80. Lee, M.K., Xu, Z., Wong, P.C. and Cleveland, D.W. (1993) Neurofilaments are obligate heteropolymers in vivo. J Cell Biol., 122, 1337-1350.
81. Liem, R.K. and Hutchison, S.B. (1982) Purification of individual components of the neurofilament triplet: Filament assembly from the 70 000-dalton subunit. Biochemistry, 21, 3221-3226.
82. Geisler, N. and Weber, K. (1981) Self-assembly in vitro of the 68,000 molecular weight component of the mammalian neurofilament triplet proteins into intermediate-sized filaments. J Mol. Biol., 151, 565-571.
83. Leung, C.L. and Liem, R.K. (1996) Characterization of interactions between the neurofilament triplet proteins by the yeast two-hybrid system. J Biol. Chem., 271, 14041-14044.
84. Zhai, J., Lin, H., Shamim, M., Schlaepfer, W.W. and Canete-Soler, R. (2001) Identification of a novel interaction of 14-3-3 with pl90RhoGEF. J Biol. Chem., 276, 41318-41324.
85. Zhai, J., Lin, H., Nie, Z., Wu, J., Canete-Soler, R., Schlaeffer, W.W. and Schlaepfer, D.D. (2003) Direct interaction of focal adhesion kinase with pl90RhoGEF. J Biol. Chem., 278, 24865-24873.
86. Meyer, D., Liu, A. and Margolis, B. (1999) Interaction of c-Jun amino-terminal kinase interacting protein-1 with p190 rhoGEF and its localization in differentiated neurons. J Biol. Chem., 274, 35113-35118.
87. van Horck, F.P., Ahmadian, M.R., Haeusler, L.C., Moolenaar, W.H. and Kranenburg, O. (2001) Characterization of pl90RhoGEF, a RhoA-specific guanine nucleotide exchange factor that interacts with microtubules. J Biol. Chem., 276, 4948-4956.
88. Ge, W., Wu, J., Zhai, J., Nie, Z., Lin, H., Schlaepfer, W.W. and Canete-Soler, R. (2002) Binding of p 190RhoGEF to a destabilizing element on the light neurofilament mRNA is competed by BC1 RNA. J Biol. Chem., 277, 42701-42705.
89. Hadano, S., Hand, C.K., Osuga, H., Yanagisawa, Y., Otomo, A., Devon, R.S., Miyamoto, N., Showguchi-Miyata, J., Okada, Y., Singaraja, R. et al. (2001) A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat. Genet., 29, 166-173.
90. Yang, Y., Hentati, A., Deng, H.X, Dabbagh, O., Sasaki, T., Hirano, M., Hung, W.Y., Ouahchi, K., Yan, J., Azim, A.C. et al. (2001) The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat. Genet., 29, 160-165.
91. Kanekura, K., Hashimoto, Y., Niikura, T., Aiso, S., Matsuoka, M. and Nishimoto, I. (2004) Alsin, the product of ALS2 gene, suppresses SOD1 mutant neurotoxicity through RhoGEF domain by interacting with SOD1 mutants. J Biol. Chem., 279, 19247-19256.
92. Chen, Y.Z., Bennett, C.L., Huynh, H.M., Blair, I.P., Pals, I, Irobi, J., Dierick, I, Abel, A., Kennerson, M.L., Rabin, B.A. et al. (2004) DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am. J. Hum. Genet., 74, 1128-1135.
93. Canete-Soler, R., Reddy, K.S., Tolan, D.R. and Zhai, J. (2005) Aldolases A and C are ribonucleolytic components of a neuronal complex that regulates the stability of the light-neurofilament mRNA. J Neurosci., 25, 4353-4364.
94. Zhai, J., Lin, H., Cañete-Soler, R. and Schlaepfer, W.W. (2005) HoxB2 binds mutant SOD1 and is altered in transgenic model ALS. Hum. Mol. Genet., 14, 2692-2640.